Companies partner to perform trials of antimicrobial topical treatmentJanuary 9, 2019Stonehaven Incubate and antimicrobial protein specialist Lysando have agreed to jointly conduct proof-of-concept trials for new topical treatments based on Artilysin, a new antimicrobial platform technology.
SPONSORED CONTENTAre Your Patients Fully Protected?Fleas, ticks, heartworms, and intestinal parasites—dogs face multiple threats. See how a multi-parasite approach can offer your patients a broad range of protection. + Learn More
FDA to study reducing use of dogs in trialsNovember 22, 2018The U.S. Food and Drug Administration (FDA) is proposing a study to help establish a non-animal based model to potentially replace the need to use dogs in future trials with new informatics tools.
